Successful Site Consolidation
Novacyt consolidated their business footprint into a single Center of Excellence in Manchester, achieving GBP 3 million in savings on top of GBP 5 million from initial synergies.
Reproductive Health Growth
Reproductive health segment showed a 26% year-on-year growth, with significant contributions from cystic fibrosis and NIPT products.
Resolution of DHSC Dispute
Successfully resolved the Department of Health and Social Care dispute, resulting in a net cash inflow of over GBP 7 million.
Strong Gross Margin
Achieved an underlying gross margin of 63%, driven by strong sales in the PCR product range.
Reduction in EBITDA Loss
Reduced the EBITDA loss by over 20%, down to GBP 9.1 million.
Strategic Investment in R&D
Reinvested over GBP 2 million into R&D to drive organic growth, with expectations of incremental sales in H2.